832 related articles for article (PubMed ID: 20698860)
1. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction].
Han YL; Cheng C; Tan HM; Wu WK; Wu YL; Sun HL; Sun J; Chen JL
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
4. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca
Ji XW; Lyu HJ; Zhou GH; Wu B; Zhu YY; Wu TH; Zhang F; Jin SN; Cho KW; Wen JF
Phytomedicine; 2021 Jan; 81():153410. PubMed ID: 33285470
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
Sharma S; Singh M; Sharma PL
Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
Jin L; Caldwell RB; Li-Masters T; Caldwell RW
J Physiol Pharmacol; 2007 Jun; 58(2):191-206. PubMed ID: 17622691
[TBL] [Abstract][Full Text] [Related]
7. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism.
Wang S; Wright G; Harrah J; Touchon R; McCumbee W; Geng W; Fultz ME; Abdul-Jalil MN; Wright GL
Can J Physiol Pharmacol; 2000 Jun; 78(6):500-6. PubMed ID: 10914640
[TBL] [Abstract][Full Text] [Related]
8. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine.
Zhang BQ; Hu SJ; Qiu LH; Zhu JH; Xie XJ; Sun J; Zhu ZH; Xia Q; Bian K
Vascul Pharmacol; 2007 Apr; 46(4):278-85. PubMed ID: 17196887
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition.
Lan TH; Xu ZW; Wang Z; Wu YL; Wu WK; Tan HM
Biochem Pharmacol; 2011 Jul; 82(2):148-55. PubMed ID: 21515242
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine reduces protein S-nitrosylation in endothelium.
Chen Y; Zhao S; Wang Y; Li Y; Bai L; Liu R; Fan J; Liu E
Int J Mol Med; 2014 Nov; 34(5):1277-85. PubMed ID: 25189662
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries.
Chen C; Conklin BS; Ren Z; Zhong DS
J Surg Res; 2002 Jan; 102(1):22-30. PubMed ID: 11792147
[TBL] [Abstract][Full Text] [Related]
12. Phytoestrogen α-zearalanol improves vascular function in ovariectomized hyperhomocysteinemic rats.
Zhen PP; Duan JH; Zhao Q; Hou DD; Wang HX; Hong N; Zhen HX; Wang W
Atherosclerosis; 2011 Apr; 215(2):309-15. PubMed ID: 21292265
[TBL] [Abstract][Full Text] [Related]
13. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta.
Toba H; Gomyo E; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Asayama J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2006; 33(5-6):440-7. PubMed ID: 16700876
[TBL] [Abstract][Full Text] [Related]
14. The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine.
Xu Z; Lan T; Wu W; Wu Y
J Vasc Surg; 2011 Jan; 53(1):156-64. PubMed ID: 20801605
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation.
Santhanam AV; Viswanathan S; Dikshit M
Eur J Pharmacol; 2007 Oct; 572(2-3):189-96. PubMed ID: 17640632
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell dysfunction in a model of oxidative stress.
Jin L; Abou-Mohamed G; Caldwell RB; Caldwell RW
Med Sci Monit; 2001; 7(4):585-91. PubMed ID: 11433181
[TBL] [Abstract][Full Text] [Related]
19. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.
Shukla N; Koupparis A; Jones RA; Angelini GD; Persad R; Jeremy JY
Eur J Pharmacol; 2006 Feb; 531(1-3):201-8. PubMed ID: 16451799
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
